Document is current
Any future updates will be listed below
-
Authors
Yum, Chaehyun
Schaefer, Richard A. https://orcid.org/0000-0001-9938-1920
Wang, Rui
Wang, Ting-You https://orcid.org/0000-0003-4354-3198
Lu, Xiaotong
Liu, Qi
Ren, Yanan
Meng, Qingshu https://orcid.org/0000-0001-8093-7482
Yang, Yongyong
Zhang, Xin
Xiong, Yan
Yu, Xufen https://orcid.org/0000-0001-7794-7890
Zhang, Xiaoyu
Jin, Jian https://orcid.org/0000-0002-2387-3862
Dong, Xuesen https://orcid.org/0000-0002-3115-3371
Yi, Yang https://orcid.org/0000-0002-1958-7249
Yang, Rendong https://orcid.org/0000-0002-9512-2240
- License Information
-
More Information
Article History
Received: 4 July 2024
Revised: 6 June 2025
Accepted: 19 June 2025
First Online: 12 July 2025
Competing interests
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: JJ is a cofounder and equity shareholder in Cullgen, Inc., a scientific cofounder and scientific advisory board member of Onsero Therapeutics, Inc., and a consultant for Cullgen, Inc., EpiCypher, Inc., Accent Therapeutics, Inc, and Tavotek Biotherapeutics, Inc. The Jin laboratory received research funds from Celgene Corporation, Levo Therapeutics, Inc., Cullgen, Inc. and Cullinan Oncology, Inc. Other authors declare no conflicts of interest.
